When TNF inhibitors fail in RA—weighing up the options

被引:0
|
作者
Lucia Silva-Fernandez
Kimme Hyrich
机构
[1] Arthritis Research UK Centre for Epidemiology,
[2] Centre for Musculoskeletal Research,undefined
[3] Institute of Inflammation and Repair,undefined
[4] the University of Manchester,undefined
[5] Manchester Academic Health Science Centre,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
What is the best rheumatoid arthritis therapy after failure of a first anti-TNF drug? No consensus has been reached on whether to switch to rituximab or an alternative TNF inhibitor. New observational studies suggest that either course can be effective. But are more data needed?
引用
收藏
页码:262 / 264
页数:2
相关论文
共 50 条
  • [1] RHEUMATOID ARTHRITIS When TNF inhibitors fail in RA-weighing up the options
    Silva-Fernandez, Lucia
    Hyrich, Kimme
    NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (05) : 262 - 264
  • [2] WEIGHING UP THE OPTIONS
    不详
    MANUFACTURING CHEMIST, 1988, 59 (11): : 39 - 40
  • [3] Weighing up the options
    Gooding, Steve
    Highways, 2019, 88 (02):
  • [4] WEIGHING UP THE OPTIONS
    不详
    MANUFACTURING CHEMIST, 1993, 64 (12): : 30 - 31
  • [5] WEIGHING UP THE OPTIONS
    不详
    MANUFACTURING CHEMIST, 1990, 61 (12): : 33 - 33
  • [6] Weighing up the calibration options
    Novaweigh
    Process Eng (London), 2 (29-30):
  • [7] Weighing up the options on quarantine
    不详
    VETERINARY RECORD, 1998, 142 (13) : 317 - 317
  • [8] WEIGHING UP THE CALIBRATION OPTIONS
    MARKLEW, C
    PROCESS ENGINEERING, 1995, 76 (02) : 29 - 30
  • [9] Topotecan: Weighing in when there are many options
    Penson, RT
    Seiden, MV
    ONCOLOGIST, 2005, 10 (09): : 698 - 700
  • [10] Slag grinding: Weighing up the options
    Longhurst, D.
    Weihrauch, M.
    World Cement, 2001, 32 (07):